Unicycive Therapeutics Files Definitive Proxy Materials

Ticker: UNCY · Form: DEFA14A · Filed: Apr 30, 2026 · CIK: 0001766140

Unicycive Therapeutics, Inc. DEFA14A Filing Summary
FieldDetail
CompanyUnicycive Therapeutics, Inc. (UNCY)
Form TypeDEFA14A
Filed DateApr 30, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-filing, shareholder-materials, corporate-governance

Related Tickers: UNCY

TL;DR

UNCY filed proxy docs 4/30/26 - shareholders vote soon.

AI Summary

Unicycive Therapeutics, Inc. filed a DEFA14A form on April 30, 2026, which contains additional definitive proxy soliciting materials. The filing includes documents related to shareholder communications and corporate governance. The company's mailing and business address is 1975 W. El Camino Real, Suite 204, Mountain View, CA 94040.

Why It Matters

This filing provides shareholders with important information regarding Unicycive Therapeutics' upcoming meetings and voting matters, impacting their ability to participate in corporate decisions.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of proxy materials and does not inherently represent a change in the company's financial or operational risk.

Key Players & Entities

  • Unicycive Therapeutics, Inc. (company) — Filer of the DEFA14A
  • 0001766140 (company) — CIK number for Unicycive Therapeutics, Inc.
  • 2026-04-30 (date) — Filing date of the DEFA14A
  • 1975 W. El Camino Real, Suite 204, Mountain View CA 94040 (address) — Mailing and Business Address for Unicycive Therapeutics, Inc.

FAQ

What type of SEC filing is this?

This is a DEFA14A filing, which signifies Additional definitive proxy soliciting materials and Rule 14(a)(12) material.

When was this filing accepted by the SEC?

The filing was accepted on April 30, 2026.

What is the CIK number for Unicycive Therapeutics, Inc.?

The CIK number for Unicycive Therapeutics, Inc. is 0001766140.

What is the business address of Unicycive Therapeutics, Inc.?

The business address is 1975 W. El Camino Real, Suite 204, Mountain View, CA 94040.

What SIC code is associated with Unicycive Therapeutics, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2026 regarding Unicycive Therapeutics, Inc. (UNCY).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.